Growth Metrics

Ainos (AIMD) EBIAT (2016 - 2025)

Ainos (AIMD) has disclosed EBIAT for 16 consecutive years, with -$2.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIAT rose 20.75% year-over-year to -$2.9 million, compared with a TTM value of -$15.0 million through Sep 2025, up 7.29%, and an annual FY2024 reading of -$14.9 million, down 7.93% over the prior year.
  • EBIAT was -$2.9 million for Q3 2025 at Ainos, up from -$4.1 million in the prior quarter.
  • Across five years, EBIAT topped out at -$534006.0 in Q1 2021 and bottomed at -$7.8 million in Q3 2022.
  • Average EBIAT over 5 years is -$3.0 million, with a median of -$2.9 million recorded in 2025.
  • The sharpest move saw EBIAT plummeted 574.22% in 2022, then soared 61.95% in 2023.
  • Year by year, EBIAT stood at -$1.4 million in 2021, then plummeted by 47.5% to -$2.1 million in 2022, then plummeted by 178.01% to -$5.9 million in 2023, then rose by 21.44% to -$4.7 million in 2024, then skyrocketed by 37.01% to -$2.9 million in 2025.
  • Business Quant data shows EBIAT for AIMD at -$2.9 million in Q3 2025, -$4.1 million in Q2 2025, and -$3.3 million in Q1 2025.